Rosewood’s PE Arm Invests in Another Manufacturer of Dietary Supplements

Rosewood Private Investments, the private equity arm of Dallas-based Rosewood Corp., has made a “majority investment” in ProTec Laboratory, a provider of contract manufacturing services to consumer brands in the dietary supplements, sports nutrition, functional foods, and pet-care products industries. Quitman, Texas-based ProTec has production capabilities including the development, manufacture, and filling of powder, liquid, tablet, capsule, and soft-gel products for a diverse customer base. The investment in ProTec marks the third within Rosewood Private Investments’ holding company, International Nutrition and Wellness Holdings—and the second this year. In July, International Nutrition snapped up Irving-based Healthy Natural Inc., another contract manufacturer.… Full Story

Dr. Arthur Hong Receives THR Clinical Scholar Award

The Texas Health Resources Clinical Scholar Award has been given to Dr. Arthur Hong, assistant professor of internal medicine and clinical sciences at UT Southwestern Medical Center, for his research into how to improve the cost, quality, and delivery of healthcare. Hong is the second recipient of the award, which provides $696,000 over a three-year period, following Dr. Bradley Lega, an assistant professor of neurological surgery, neurology and neurotherapeutics, and psychiatry at UT Southwestern Medical Center. Hong’s work is said to align closely with the primary mission of Southwestern Health Resources, an integrated health network launched in 2015 by UT… Full Story

Report Describes Dallas Biotech Company’s Anti-Cancer Vaccines

A new report focuses on the development of more than 260 vaccines to prevent and treat illnesses by U.S. biopharmaceutical companies, including Gradalis, a biotechnology company based  in Dallas. The report from the Pharmaceutical Research and Manufacturers of America says a “robust pipeline” of vaccines in development includes 137 for infectious diseases, 101 for cancer, 10 for allergies, eight for autoimmune disease, four for Alzheimer’s disease, and five for other diseases. Among companies developing the 101 anti-cancer vaccines, Gradalis is highlighted. The local company is developing treatments for advanced ovarian cancer (with a Phase III trial); advanced breast cancer (Phase… Full Story

Medical City Alliance Names New Chief Nursing Officer

Medical City Alliance has named Dean Miller as its new chief nursing officer. Miller, who starts Dec. 11, succeeds Judith Messer, who recently accepted the chief nursing officer position with Wesley Medical Center in Wichita, Kansas. (Wesley Medical, like Medical City, is owned by HCA.) Miller’s experience includes 12 years in healthcare, developing service lines and establishing patient, physician, and employee relationships. A registered nurse, he joined Medical City Healthcare in 2010 as director of ICU at Medical City Arlington. He’s also served as associate vice president of critical care services and associate chief nursing officer at Medical City Denton.… Full Story

Doctors Sell A Clinic Building in Colleyville

The doctors who work at and owned a Colleyville clinic building have sold it to Provlepsi LLC for an undisclosed sum. The 10,779-square-foot Family Healthcare Associates-Colleyville Clinic building on Brown Trail had been purchased as an investment by the doctors who work there 12 years ago. The facility, built by HCA Healthcare in 1995, was first leased to—and then bought by—NEDOCS LLC, the holding company for the doctors, in 2005. The doctors with Family Healthcare Associates, who will continue to maintain operations in the building, focus on primary care, diagnostic services, gynecology, and after-hours care. According to the seller’s representatives,… Full Story

Eosera Launches Its Earwax Product in Canada

Eosera Inc., a biotech company based in Fort Worth, has begun offering its earwax-dissolving product on the Canadian market via The product called Earwax MD, which is designed to clean the ear canal, is the first from Eosera, a majority woman-owned company. Eosera began selling Earwax MD on Amazon in April, and the over-the-counter product has been stocked nationwide in CVS stores since August. “Since launching Earwax MD on in April, we have received considerable interest from Canadian consumers, audiologists, ENTs, and other healthcare professionals,” Elyse Dickerson, Eosera’s co-founder and CEO, said in a news release. “We are… Full Story

Nurse-Midwives Playing a Key Role in Parkland’s Labor and Delivery Department

Parkland Health & Hospital System is marking its 30th year with certified nurse-midwives playing a key role in its labor and delivery department. The department, one of the nation’s busiest, tallied more than 12,000 births in fiscal year 2017. Parkland nurse-midwives attended 40 percent of all vaginal deliveries, or about 300 births a month. Since they were first recruited to Parkland in 1987, nurse-midwives have attended 420,000 births there. The 36 certified nurse-midwives currently practicing at Parkland constitute one of the largest and most respected certified nurse-midwives services in the country. Safely guiding women through one of the most vulnerable,… Full Story

President-elect of American Society of Breast Surgeons To Use Game Theory to Teach Surgeons About Genetics

Dr. Walton Taylor—a breast surgeon on the medical staff of Texas Health Dallas who’s been elected president-elect of The American Society of Breast Surgeons—wants to use game theory to help breast surgeons better understand the role that genetics plays in cancer. The American Society of Breast Surgeons, which has more than 3,000 members in 36 countries, is the primary leadership group for surgeons who treat patients with breast disease. Taylor, a physician with Texas Health Physicians Group and a member of the society since 2002, will assume the role of the organization’s president in May of 2018. Taylor said that… Full Story

Cooper Clinic Laboratory Receives Excellence Award

For the seventh year, the Cooper Clinic Laboratory in Dallas has been selected to receive the COLA Laboratory Excellence Award. The award, which signifies a commitment to performing quality patient testing and overall laboratory practices, has been given over the years to only a small percentage of U.S. labs. COLA is a nonprofit, physician-directed organization promoting quality and excellence in medicine and patient care. The Cooper Clinic Laboratory team processes nearly 300,000 tests per year, including those involving a patient’s cholesterol profile, blood sugar levels, urinalysis, and thyroid stimulating hormone. “Our … team is honored to receive this award,” Dr.… Full Story

NanOlogy Launches Phase 2 Clinical Trial for Pancreatic Cancer Treatment

Fort Worth-based NanOlogy LLC, a clinical-stage pharmaceutical development company, announced that the first patient has been enrolled in a Phase 2 clinical trial of its NanoPac sterile solution, a patented process for treating mucinous cystic neoplasms (MCNs) of the pancreas. The Phase 2 “dose-rising” trial will evaluate the safety and efficacy of NanoPac delivered directly into MCNs by endoscopic ultrasound-guided fine needle injection. “There is no approved drug treatment for patients with MCNs who are at high risk for progression to cancer,” Dr. Gere diZerega, the company’s vice president of medical affairs, said in a news release. “This clinical trial… Full Story